Hepion Pharmaceuticals, Inc.·4

Nov 28, 6:55 AM ET

Wijngaard Peter 4

4 · Hepion Pharmaceuticals, Inc. · Filed Nov 28, 2023

Insider Transaction Report

Form 4
Period: 2023-11-24
Transactions
  • Purchase

    Common Stock

    2023-11-24$3.09/sh+2,500$7,7257,001 total
  • Purchase

    Common Stock

    2023-11-27$3.05/sh+2,500$7,6259,501 total

Documents

1 file
  • 4
    tm2331632-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT